← Open Payments lookup

HANNAH THROGMORTON: Open Payments

NPI 1336920206 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,514 in 79 payments from 13 companies in 2025. Trend: 2023 $403 · 2024 $1,633 · 2025 $1,514

Food & beverage: $1,514
CompanyPaymentsAmount
ABBVIE INC.22$309
Alkermes, Inc.10$188
Otsuka America Pharmaceutical, Inc.15$187
E.R. Squibb & Sons, L.L.C.4$169
Tris Pharma Inc6$129
Teva Pharmaceuticals USA, Inc.2$125
Neos Therapeutics, LP5$87
Corium, LLC3$71
Vanda Pharmaceuticals Inc.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$64

Products named: VRAYLAR, REXULTI, COBENFY, LYBALVI, UZEDY, Onyda XR, Adzenys XR-ODT, Azstarys.

Industry payments across TX — which companies pay providers there.